Isharwal, Sumit <br/><br/>
DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.  [electronic resource] 

 -  Urology  May 2009 
 - 1092-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1527-9995 
<br/><br/><label>Standard No.: </label>10.1016/j.urology.2008.09.060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analysis of Variance<br/>Area Under Curve<br/>Biopsy, Needle<br/>Cohort Studies<br/>DNA--analysis<br/>Genetic Markers--genetics<br/>Humans<br/>Immunohistochemistry<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness--genetics<br/>Neoplasm Staging<br/>Ploidies<br/>Predictive Value of Tests<br/>Preoperative Care--methods<br/>Probability<br/>Prognosis<br/>Prospective Studies<br/>Prostatectomy--methods<br/>Prostatic Neoplasms--genetics<br/>ROC Curve<br/>Risk Assessment<br/>Sensitivity and Specificity<br/>Survival Rate<br/>Treatment Outcome